{"id":44747,"date":"2022-06-06T15:01:29","date_gmt":"2022-06-06T13:01:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/"},"modified":"2022-06-06T15:01:29","modified_gmt":"2022-06-06T13:01:29","slug":"soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/","title":{"rendered":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae"},"content":{"rendered":"
\n

\nCompany to Distribute FDA-Approved Treatment for Neuromyelitis Optica Spectrum Disorder<\/i>\n<\/p>\n

FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare<\/a>—Soleo Health<\/a>, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG\u00ae<\/a> (satralizumab-mwge), manufactured by Genentech<\/a>, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with severe and life-threatening diseases.\n<\/p>\n

<\/a><\/p>\n

\nSoleo Health now provides ENSPYRNG to patients with Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare autoimmune disease of the optic nerve, brain and spinal cord, who are anti-aquaporin-4 (AQP4) antibody positive. ENSPYRNG, a Food & Drug Administration-approved subcutaneous treatment, is administered by patients or caregivers every four weeks. ENSPRYNG is a different kind of treatment in that it is the first and only approved NMOSD therapeutic designed to block the action of interleukin 6 (IL-6)\u2014a protein that may play a vital role in this chronic condition.\n<\/p>\n

\nSoleo Health\u2019s extensive expertise in providing care for patients \u2013 particularly those targeted at treating rare or ultra-rare diseases \u2013 makes the Company an appropriate and experienced candidate to bring ENSPRYNG to patients.\n<\/p>\n

\nFurthermore, Soleo Health\u2019s proprietary clinical outcomes program, SoleMetrics\u00ae<\/a>, which collects and produces valuable real-world data over time, will gather intelligent outcomes from patients throughout their ENSPRYNG journeys to provide clinical and economic value to key stakeholders.\n<\/p>\n

\n\u201cWe continue to forge integral, strong limited distribution partnerships with pharmaceutical manufacturers to aid in advancing the distribution and administration of many proven therapies. In turn, our drug manufacturer partners find our services, clinical care and data highly advantageous to improving patient care,\u201d said Drew Walk, Soleo Health chief executive officer.\n<\/p>\n

\nAbout Soleo Health<\/b>\n<\/p>\n

\nSoleo Health<\/a> is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care. Soleo Health\u2019s interdisciplinary clinical team comprises highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors. The Company optimizes patient access solutions and delivers comprehensive services, leading to quantifiable clinical and economic value, resulting in positive patient experiences.\n<\/p>\n

\nSoleo Health operates 21 locations<\/a> throughout the U.S. with national nursing coverage and pharmacy licensure in 50 states and is accredited by URAC, ACHC with Distinction in Rare Disease and Orphan Drugs and The Joint Commission.\n<\/p>\n

\nVisit www.soleohealth.com<\/a> or connect with Soleo Health on LinkedIn<\/a>, Facebook<\/a> and Twitter<\/a> for more information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSusan Turkell, 303-766-4343, sturtkell@soleohealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to Distribute FDA-Approved Treatment for Neuromyelitis Optica Spectrum Disorder FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG\u00ae (satralizumab-mwge), manufactured by Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44747","6":"format-standard","7":"category-industry"},"yoast_head":"\nSoleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company to Distribute FDA-Approved Treatment for Neuromyelitis Optica Spectrum Disorder FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG\u00ae (satralizumab-mwge), manufactured by Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-06T13:01:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae\",\"datePublished\":\"2022-06-06T13:01:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/\"},\"wordCount\":410,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005152\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/\",\"name\":\"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005152\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"datePublished\":\"2022-06-06T13:01:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005152\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005152\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/","og_locale":"en_US","og_type":"article","og_title":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend","og_description":"Company to Distribute FDA-Approved Treatment for Neuromyelitis Optica Spectrum Disorder FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG\u00ae (satralizumab-mwge), manufactured by Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-06T13:01:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae","datePublished":"2022-06-06T13:01:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/"},"wordCount":410,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/","url":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/","name":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","datePublished":"2022-06-06T13:01:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220606005152\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-named-to-genentechs-limited-drug-distribution-network-for-provision-of-enspryng\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Soleo Health Named to Genentech\u2019s Limited Drug Distribution Network for Provision of ENSPRYNG\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44747"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44747\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}